Directory
>
Werner Gladdines
Werner Gladdines
Chief Development Officer (CDO) | Immunic Therapeutics
Oegstgeest, South Holland, Netherlands
Werner Gladdines
Summary
Werner Gladdines is a seasoned drug development executive with over 19 years of experience in global clinical operations and clinical sciences, particularly in oncology, neurology, and metabolic orphan diseases. He has played a pivotal role in the registration of three medicinal products and has successfully led investigational products through various clinical phases. His extensive knowledge of FDA and EMA regulations complements his strong leadership skills, having managed teams of up to 40 FTE across numerous international clinical studies. Werner is passionate about operational excellence and innovation within clinical development operations. His academic background in Bio-Pharmaceutical Sciences from Leiden University enhances his technical expertise in biopharmaceuticals and biotechnology. Additionally, he has contributed to several significant publications in the field, showcasing his commitment to advancing medical science.
Werner Gladdines
Work Experience
Chief Development Officer (CDO) at
Immunic Therapeutics
July 2024 - Present
VP, Program Management & Clinical Development Operations at
Immunic Therapeutics
February 2023 - July 2024
VP, Clinical Development Operations at
Immunic Therapeutics
August 2021 - February 2023
Head of Clinical Program IMU-838 at
Immunic Therapeutics
January 2021 - July 2021
Sr. Director Clinical Sciences at
AIMM Therapeutics B.V.
December 2019 - December 2020
Executive Director, Head of European Clinical Operations at
Rainier Therapeutics
March 2017 - November 2019
Owner and Director at
Bulls Eye Drug Development Consultancy
May 2016 - November 2019
Sr. Director Clinical Operations at
BioMarin Pharmaceutical Inc.
July 2015 - December 2016
Member at
JCI Haaglanden
January 2010 - December 2016
Clinical Director Research and Development at
BioMarin Pharmaceutical Inc.
January 2015 - June 2015
Head of Development at
BBB Therapeutics
June 2009 - November 2014
Chair of JCI Haaglanden 2011 at
JCI Haaglanden
January 2011 - December 2011
Clinical Operations Consultant at
Sanofi
June 2010 - December 2010
EU Clinical Lead (Sr. Clinical Project Manager) at
Genzyme Europe B.V.
February 2008 - May 2009
European Team Leader at
SANOFI-AVENTIS AUSTRALIA PTY LTD
January 2006 - January 2008
Clinical Project Manager at
SANOFI-AVENTIS AUSTRALIA PTY LTD
March 2005 - January 2008
Clinical Research Associate at
Genzyme Europe B.V.
June 2002 - March 2005
Intern Student at
ROCHE LEON HOLDINGS
January 2001 - January 2001
Werner Gladdines
Education
Dutch Institute of Marketing (NIMA A)
January 2002 - January 2003
Leiden University, Msc
January 1996 - January 2001
Frequently Asked Questions about Werner Gladdines
What is Werner Gladdines email address?
Werner Gladdines's primary email address is **********@imux.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Werner Gladdines work for?
Werner Gladdines is a Chief Development Officer (CDO) at Immunic Therapeutics, a company specializing in Commercial physical research.
Where Werner Gladdines graduated from?
Werner Gladdines holds a degree in from Dutch Institute of Marketing (NIMA A).
How can I directly contact Werner Gladdines?
To contact Werner Gladdines directly, you can use the email address **********@imux.com. Complete contact information is available upon registration with Muraena.
Who is Werner Gladdines?
Werner Gladdines is a seasoned drug development executive with over 19 years of experience in global clinical operations and clinical sciences, particularly in oncology, neurology, and metabolic orphan diseases. He has played a pivotal role in the registration of three medicinal products and has successfully led investigational products through various clinical phases. His extensive knowledge of FDA and EMA regulations complements his strong leadership skills, having managed teams of up to 40 FTE across numerous international clinical studies. Werner is passionate about operational excellence and innovation within clinical development operations. His academic background in Bio-Pharmaceutical Sciences from Leiden University enhances his technical expertise in biopharmaceuticals and biotechnology. Additionally, he has contributed to several significant publications in the field, showcasing his commitment to advancing medical science.
Werner`s contact details
**********@imux.com
Colleagues
Chief Financial Officer
Chief Executive Officer
Executive Chairman
Vice President Investor Relations and Communications